http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009118753-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_582935c298a0557261f90a9395eb3eb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_233d87434a1859a2147a1b752b942f1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2919a384e8471477b61879f48477938
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ef2a06d7c1e491f1eafa6dd9d1e3afe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faeb62e37066632bda28d82c796044ba
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
filingDate 2009-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84357ae647311d10df264aec7ecdb44f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_919386dcf752c65adac86cab2e8d0ddd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c3e763ea0a18cc351f530d79fa17e99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_120151d98eac443f1c8aaaf639648b02
publicationDate 2010-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2009118753-A3
titleOfInvention Process for preparation of naratriptan hydrochloride
abstract The present invention relates to an improved process for the preparation of N-methyl-3- (l-methyl-4-piperidinyl)-lH-indole-5-ethanesulfonamide hydrochloride of formula (I) having less than 0.15% area by HPLC of 3-(l-methyl-4-piperidinyl)-lH-indole-5- ethanesulfonamide (IA) and intermediates thereof.
priorityDate 2008-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008056378-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4997841-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009016466-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008072257-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5659040-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426536
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14392652
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68572478
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229258784
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60875
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4440
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229294636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226449465

Total number of triples: 40.